return equiti ttm
matur commerci initi meaning pipelin updat show
path back sustain acceler growth
solid underli momentum neg affect headwind exclud
neg impact manag estim global impella sale would
grown year-over-year million lost sale basi point repres steadi
momentum last quarter roughli year-over-year growth encourag
see solid underli momentum core busi suggest manag
commerci clinic effort gain traction procedur cancel began
second half march specif expect compani benefit expand
matur salesforc increas physician train effort includ manag
roadshow stronger podium presence/clin roadmap robust product pipelineal
help util adopt impella overal believ underli
momentum suggest well posit sustain growth move
back normalci mani commerci effort readi contribut
sale meaning come quarter
meantim manag note impella patient volum declin approxim
mid-march april elect procedur delay extent
emerg case neg affect lower patient volum heavili impact
citi declin rel widespread unit state europ
although japan remain strong quarter growth like worsen
countri declar state emerg earlier month elect procedur
someth survey work rel posit estim account acut
headwind first quarter sale declin year-over-year sequenti
improv rest year
guidanc color sequenti improv encourag given
uncertainti speed elect case ramp potenti effect
urgent case manag provid fiscal guidanc still provid detail
commerci strategi rest year focu week-to-week improv
follow outsiz neg impact first fiscal quarter specif manag
laid three-tier red-yellow-green approach fiscal first quarter red
phase suggest stabilization/cost-reduct period red phase may move
fiscal second quarter though could see begin recoveri yellow phase
elect case get reschedul urgent case gain physician attent compani
cite sever reason alreadi start potenti turn favor even first
quarter yellow evolv green phase second half fiscal
rep get back account ramp train effort increas manufactur
manag suggest green phase return growth year-over-year basi
impli growth second half year
make number cardiac-assist devic treat acut heart failur compani portfolio
highlight impella product first percutan catheter-bas cardiac assist devic
headwind larg line prior survey work survey link lower
fiscal estim account meaning headwind urgent case well
pleas refer import disclosur page analyst certif page
william blair affili seek busi compani cover research report
result investor awar firm may conflict interest could affect object
report report intend provid person invest advic opinion recommend
herein take account individu client circumst object need intend
recommend particular secur financi instrument strategi particular client recipi
report must make independ decis regard secur financi instrument mention
although seem exact timelin littl fuzzi seem month-to-month basi growth
return septemb decemb lead confid reach growth later year larg expect
similar compani coverag univers though manag commentari prepared shift
virtual proctor educ seem line ahead peer ultim walk away think
short term impact compani make valuabl invest remain winner end
product pipelin updat offer addit catalyst growth earlier bullet one larger surpris call
manag confid pipelin near-term catalyst motiv potenti acceler
timelin effort includ acceler roll-out remot interfac technolog maintain timelin
new product like expand sheath ecp compani seem delay expens
manag confid even near-term approv encourag
compani launch strategi encompass multipl driver deliv
interact on-line portal train educ patient support initi compani
acceler roll-out smartassist impella connect technolog smartassist use
 site assist impella procedur impella connect expand new site quarter
hospit on-line hardwar instal technolog expect launch major
hospit end fiscal year lastli manag also launch pci on-line interact
educ train effort help train clinician impella cp devic allow sale rep
kol virtual perform proctor live case also interact virtual attende manag highlight
recept desir physician partak virtual class given level interact
conveni provid virtual portal start build virtual capabl
meaning year seem well prepar on-going shift virtual presenc
believ virtual presenc support system import differenti across coverag univers
although manag cite rep larg deem essenti personnel enter hospit
someth vari across coverag extens on-line support train effort allow
reach even account base frequent
expand sheath manag expect submit approv expand sheath impella
devic fiscal second quarter approv process expect last day impli launch fiscal third
quarter calendar year-end follow similar submiss cp pump made
unit sale fiscal impli approv end fiscal year track manag prior
guidanc despit materi launch expand sheath allow impella cp
implant french access cathet offer nearli reduct cathet size current french
help address concern larg bore access closur among next leg impella adopt
manag point lack comfort case skill larg bore access closur key factor
ecp although full commerci launch devic littl compar expand sheath
manag expect ecp use hospit unit state fiscal year ahead origin
expect commerci product develop plan first-in-man march europ
travel restrict prevent case take place unit state submit earli feasibl studi
fda day respond request approv move forward feasibl trial
potenti flip formal pilot studi pilot studi leverag particip center
pivot studi gather data eventu pma file final pivot trial run impella cp
show equival safeti effect alreadi approv devic full commerci roll-out ecp
still like time develop potenti final product plan meaning human use fiscal
well ahead expect demonstr compani urgenc execut pipelin
context ecp repres next major breakthrough offer similar flow rate impella cp
liters/minut true french pump design smaller access site cp put anoth way ecp provid
physician three four time flow rate iabp mention superior lv unload characterist
associ impella compar size access tradit iabp
random controlled-tri rct like delay compani recent establish rct
roadmap due manag expect six-month delay stemi particular manag reiter
confid run three trial continu execut establish center particip
trial recal plan run three size rigor need secur class impella
recommend within stemi alreadi enrol current paus hrpci protect iv cardiogen shock
recov iv time latter two trial still somewhat unclear given delay expect hear
concret detail manag late-may investor day switch virtual meet either way
manag continu dedic front encourag continu believ even enrol
mileston trial could act stock catalyst come year
note reimburs manag spoke candidli expect fiscal ipp rate
potenti propos cut drg current main impella drg code reiter confid hospit
abil still profit use impella devic histor releas propos rate late april although
could delay process reason real-world drg reimburs rate end higher cite
propos file geograph kicker outlier payment etc support impella use regardless propos
reimburs cut manag also highlight breeth acquisit strategi expand list
applic drg code impella use mitig lower price give option reimburs
larg comfort potenti lower rate next ipp updat believ impella continu gain
adopt util move forward
breeth acquisit offer potenti synergi ecmo also announc acquisit breeth portabl
ecmo machin complement portfolio product aim support patient ambul ultim nativ heart
recoveri manag highlight system portabl eas use competit differenti current ecmo
devic could allow market share gain exist annual domest case opportun perhap even
meaning potenti synergist impella sale perform ecpella case ecmo use
oxygen blood impella use unload left ventricl support end organ manag estim roughli
ecmo case could benefit impella use could provid tailwind adoption/util time
nonetheless revenu contribut breeth fiscal either devic impella pull-through
wait clearanc initi traction compani limit releas fiscal fourth quarter earli
calendar believ acquisit help round mechan circulatori support portfolio system
aim nativ heart recoveri wait meaning execut increas estim move forward
focus breeth system competit advantag potenti steal market share well clinic data
public ecpella capabl deliv pull-through impella date breeth clinic user
top physician suggest could strong initi traction within account
strong balanc sheet end fiscal million cash last fiscal year debt
compani continu deliv strong margin gross oper fiscal support strong oper
cash flow million year headwind like hit margin come quarter manag
take cost-cut measur execut pay cut hire freez less travel etc help mitig effect overal
forecast million free cash flow fiscal end fiscal year
million cash still debt believ leav strong posit continu invest long-term
growth strategi come quarter
conclus stock thought
near-term result certainli neg affect encourag continu
underli momentum second quarter roughli growth ex-covid demonstr earli benefit
recent commerci clinic effort reacceler growth came away fourth-quart call encourag
manag dedic long-term growth initi thought materi posit updat
clinic larg track pipelin expand time ecp ahead schedul initi taken togeth
believ well posit emerg environ matur commerci initi
expand matur salesforc bolster clinic back aim class recommend support sustain
acceler growth larg under-penetrated market clinic valid solut share trade time
calendar revenu estim million growth rate stock outperform
abiom growth heavili depend continu increas adopt util singl product impella
compani unabl suffici demonstr clinic econom benefit impella growth
neg impact physician curtail use pump near term compani must also refut recent
present data suggest poor outcom impella devic potenti slow growth impella use
long term clinic data collect remain import compani also like need execut pipelin
product capabl support widespread use pump delay inabl execut pipelin product
need regulatori approv well limit long-term growth
newpreviouschang newpreviouschang us impella growth margin margin summari chang modelfisc import disclosur
